Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 92

1.
2.

Psychological assessment in 355 Chinese college students with androgenetic alopecia.

Wang X, Xiong C, Zhang L, Yang B, Wei R, Cui L, Xing X.

Medicine (Baltimore). 2018 Aug;97(31):e11315. doi: 10.1097/MD.0000000000011315.

3.

Injectable Platelet-, Leukocyte-, and Fibrin-Rich Plasma (iL-PRF) in the Management of Androgenetic Alopecia.

Schiavone G, Paradisi A, Ricci F, Abeni D.

Dermatol Surg. 2018 Sep;44(9):1183-1190. doi: 10.1097/DSS.0000000000001584.

PMID:
30045107
4.

Male pattern baldness and incidence of prostate cancer: A systematic review and meta-analysis.

He H, Xie B, Xie L.

Medicine (Baltimore). 2018 Jul;97(28):e11379. doi: 10.1097/MD.0000000000011379. Review.

5.

The tendency towards the development of psychosexual disorders in androgenetic alopecia according to the different stages of hair loss: a cross-sectional study.

Tas B, Kulacaoglu F, Belli H, Altuntas M.

An Bras Dermatol. 2018 Mar;93(2):185-190. doi: 10.1590/abd1806-4841.20185658.

6.

Possible association between androgenic alopecia and risk of prostate cancer and testicular germ cell tumor: a systematic review and meta-analysis.

Liang W, Song L, Peng Z, Zou Y, Dai S.

BMC Cancer. 2018 Mar 12;18(1):279. doi: 10.1186/s12885-018-4194-z. Review.

7.

Mechanical and Controlled PRP Injections in Patients Affected by Androgenetic Alopecia.

Gentile P, Garcovich S, Scioli MG, Bielli A, Orlandi A, Cervelli V.

J Vis Exp. 2018 Jan 27;(131). doi: 10.3791/56406.

PMID:
29443105
8.

Androgenetic alopecia; drug safety and therapeutic strategies.

Motofei IG, Rowland DL, Baconi DL, Tampa M, Sârbu MI, Păunică S, Constantin VD, Bălălău C, Păunică I, Georgescu SR.

Expert Opin Drug Saf. 2018 Apr;17(4):407-412. doi: 10.1080/14740338.2018.1430765. Epub 2018 Jan 24. Review.

PMID:
29363345
9.

Establishment and characterization of five immortalized human scalp dermal papilla cell lines.

Kwack MH, Yang JM, Won GH, Kim MK, Kim JC, Sung YK.

Biochem Biophys Res Commun. 2018 Feb 5;496(2):346-351. doi: 10.1016/j.bbrc.2018.01.058. Epub 2018 Jan 10.

PMID:
29331373
10.

Gender-specific risk factors for androgenetic alopecia in the Korean general population: Associations with medical comorbidities and general health behaviors.

Kim BK, Choe SJ, Chung HC, Oh SS, Lee WS.

Int J Dermatol. 2018 Feb;57(2):183-192. doi: 10.1111/ijd.13843.

PMID:
29330930
11.

The use of minoxidil in the treatment of male and female androgenetic alopecia: a story of more than 30 years.

Barbareschi M.

G Ital Dermatol Venereol. 2018 Feb;153(1):102-106. doi: 10.23736/S0392-0488.17.05781-9. Review.

PMID:
29319278
12.

Low-level laser therapy for the treatment of androgenic alopecia: a review.

Darwin E, Heyes A, Hirt PA, Wikramanayake TC, Jimenez JJ.

Lasers Med Sci. 2018 Feb;33(2):425-434. doi: 10.1007/s10103-017-2385-5. Epub 2017 Dec 21. Review.

PMID:
29270707
13.

Mechanism of action of minoxidil in the treatment of androgenetic alopecia is likely mediated by mitochondrial adenosine triphosphate synthase-induced stem cell differentiation.

Goren A, Naccarato T, Situm M, Kovacevic M, Lotti T, McCoy J.

J Biol Regul Homeost Agents. 2017 Oct-Dec;31(4):1049-1053.

PMID:
29254313
14.

Social selection favours offspring prone to the development of androgenetic alopecia.

Goren A, Shapiro J, Naccarato T, Situm M, Kovacevic M, Lonky N, Lotti T, McCoy J.

J Biol Regul Homeost Agents. 2017 Oct-Dec;31(4):1013-1016.

PMID:
29254307
15.

Alopecia and the metabolic syndrome.

Lie C, Liew CF, Oon HH.

Clin Dermatol. 2018 Jan - Feb;36(1):54-61. doi: 10.1016/j.clindermatol.2017.09.009. Epub 2017 Sep 8. Review.

PMID:
29241753
16.

Mediterranean diet: fresh herbs and fresh vegetables decrease the risk of Androgenetic Alopecia in males.

Fortes C, Mastroeni S, Mannooranparampil T, Abeni D, Panebianco A.

Arch Dermatol Res. 2018 Jan;310(1):71-76. doi: 10.1007/s00403-017-1799-z. Epub 2017 Nov 27.

PMID:
29181579
17.

Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men - short version.

Kanti V, Messenger A, Dobos G, Reygagne P, Finner A, Blumeyer A, Trakatelli M, Tosti A, Del Marmol V, Piraccini BM, Nast A, Blume-Peytavi U.

J Eur Acad Dermatol Venereol. 2018 Jan;32(1):11-22. doi: 10.1111/jdv.14624. Epub 2017 Nov 27.

PMID:
29178529
18.

Yellow dots in trichoscopy: relevance, clinical significance and peculiarities.

Lima CDS, Lemes LR, Melo DF.

An Bras Dermatol. 2017 Sep-Oct;92(5):724-726. doi: 10.1590/abd1806-4841.20176157.

19.

The clinical effect of JetpPeel-assisted topical minoxidil in the treatment of androgenetic alopecia: A randomized pilot study.

Gong L, Bao L, Tian T, Li Y.

J Cosmet Laser Ther. 2018 Feb;20(1):58-63. doi: 10.1080/14764172.2017.1341046. Epub 2017 Nov 22.

PMID:
29166130
20.

GWAS for male-pattern baldness identifies 71 susceptibility loci explaining 38% of the risk.

Pirastu N, Joshi PK, de Vries PS, Cornelis MC, McKeigue PM, Keum N, Franceschini N, Colombo M, Giovannucci EL, Spiliopoulou A, Franke L, North KE, Kraft P, Morrison AC, Esko T, Wilson JF.

Nat Commun. 2017 Nov 17;8(1):1584. doi: 10.1038/s41467-017-01490-8. Erratum in: Nat Commun. 2018 Jun 29;9(1):2536.

Supplemental Content

Loading ...
Support Center